Form 8-K HeartSciences Inc. For: Sep 26
HeartSciences Inc. (HSCS)
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
HSCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HSCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HSCS alerts
High impacting HeartSciences Inc. news events
Weekly update
A roundup of the hottest topics
HSCS
News
- HeartSciences (NASDAQ:HSCS) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- HeartSciences (NASDAQ:HSCS) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=HSCS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen<MarketBeat
- HeartSciences (NASDAQ:HSCS) had its price target lowered by analysts at Ascendiant Capital Markets from $15.00 to $9.00. They now have a "buy" rating on the stock.MarketBeat
- HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial Results [Yahoo! Finance]Yahoo! Finance
- HeartSciences Provides Business Update and Reports First Quarter of Fiscal 2026 Financial ResultsGlobeNewswire
HSCS
Analyst Actions
- 10/1/25 - Ascendiant Capital
HSCS
Sec Filings
- 11/28/25 - Form 4
- 11/28/25 - Form 8-K
- 11/5/25 - Form S-8
- HSCS's page on the SEC website